Mar 29, 2017, 04:41 by Michael Croft

GLASGOW, UK - Mar 29, 2017 - ProductLife Group (PLG), which specialises in helping life sciences companies stay ahead of the changing R&D landscape, has launched PLG inVolv™, a powerful artificial-intelligence-based social media listening solution to help the industry meet its pharmacovigilance obligations

Mar 28, 2017, 13:57 by Michael Croft

FDA Voice |  Mary Lou Valdez, FDA's associate commissioner for international programs, talks about the shared goals of India and the United States in drug and food safety.

Mar 28, 2017, 13:00 by Michael Croft

Clinical Informatics News | Dell has released its smallest, most power-efficient thin client, the Wyse 3040. Available for $329, the system is compatible with Citrix, Microsoft and VMware virtual workspace environments, is highly secure, and easy to deploy and manage.

Mar 27, 2017, 12:42 by Michael Croft

BOSTON - Mar 27, 2017 -    SHANGHAI; BOSTON, Mass.,  27 March, 2017 - LabNetwork, WuXi AppTec's global chemistry ecommerce platform company, today announced a new collaboration with Elsevier, a world-leading provider of scientific, technical and medical information products and services

Mar 24, 2017, 15:47 by Michael Croft

The Scripps Research Institute News |  Inspired by their own experiences, two researchers at The Scripps Research Institute and Scripps Translational Science Institute have launched The Healthy Pregnancy Study in partnership with WebMD. They will gather survey data from pregnant volunteers using the free WebMD Pregnancy app.

Mar 23, 2017, 12:19 by Michael Croft

PHILADELPHIA, PA, UNITED STATES - Mar 20, 2017 - Sponsors and CROs worldwide have elevated DrugDev to an industry milestone of over $2 billion in aggregate payments to clinical investigator sites – an accomplishment unequaled by any other provider, including all but the very largest CROs

Mar 23, 2017, 10:50 by Michael Croft

Clinical Informatics News  Earlier this week, the National Academy of Medicine released a report outlining vital directions for health and health care. Among the four priorities for action, the report highlights connected care—using technologies to link health data and improve patient experience. We agree that health technologies, connected care, and interoperability are vitally important work, and the Medical Informatics World conference in Boston in May will delve into many of those questions.

Mar 21, 2017, 10:51 by Michael Croft

Forbes |  Esperion Therapeutics says the Food and Drug Administration has agreed that the company's medicine, bempadoic acid, could be approved based on blood test results, before a larger study proving it prevents heart attacks, strokes, heart procedures, or deaths has been completed.

Mar 20, 2017, 15:12 by Michael Croft

STAT |  Researchers said that at major teaching hospitals, about 3,600 deaths in one year could be avoided if inspection-related vigilance was the norm.

Mar 20, 2017, 14:45 by Michael Croft

PUYALLUP, WA - Mar 20, 2017 - Western Institutional Review Board® (WIRB™), the world's leading provider of ethical review of clinical research, announced today the launch of its WIRB NIH Single Review Solution™ (SRS) for NIH-funded multi-site research

Mar 20, 2017, 07:56 by Michael Croft

PITTSBURGH, PA, UNITED STATES - Mar 20, 2017 - ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced it has received Omega Management Group Corporation’sNorthFace ScoreBoard (NFSB) AwardSM for consistent delivery of outstanding customer service throughout 2016

Mar 17, 2017, 10:33 by Michael Croft

STAT |  Amgen's cholesterol drug lowered risk of cardiovascular trouble in a huge clinical trial - but the results may not be good enough for insurers to cover.

Mar 16, 2017, 11:49 by Michael Croft

Xconomy |  Seres Therapeutics wants to become the first company to bring to market a drug that targets the microbiome. Its lead drug failed in clinical trials last year, but now the company is launching a new Phase 2 trials.

Mar 16, 2017, 10:07 by Michael Croft

LONDON, N/A, UK - Mar 16, 2017 - Adoption of DrugDev Spark™, the world’s first unified clinical operations suite, continues to escalate worldwide with strong demand in Europe and ROW for proven solutions including site selection, activation, eConsent, LMS and global site payments

Mar 15, 2017, 12:11 by Michael Croft

BOSTON, NY - Mar 15, 2017 - The Pistoia Alliance Tackles Laboratory Safety with the Launch of the Chemical Safety Library ServiceCollaborative database of previously inaccessible hazardous chemical reactions improves safety for scientists carrying out experiments in the labBoston, 15 March, 2017 - The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, has today announced the launch of the Chemical Safety Library (CSL) Service, which allows hazardous reaction information to be captured, stored and shared, to improve laboratory safety

Mar 15, 2017, 09:00 by Michael Croft

Clinical Informatics News | Johnson & Johnson has shared pharmaceutical and medical device data through the Yale University Open Data Access (YODA) Project, promoting scientific discovery and data transparency along the way.

Mar 14, 2017, 17:28 by Michael Croft

PASADENA, CA - Mar 14, 2017 - Deep 6 AI, an artificial intelligence-enabled technology platform for matching patients to clinical trials, took home first prize in the Enterprise and Smart Data category at the 9th annual SXSW Accelerator competition, the marquee event of the South by Southwest® (SXSW®) Conference and Festivals (March 10-19, 2017)  Startup Village®

Mar 14, 2017, 01:57 by Michael Croft

LONDON, LONDON - Mar 14, 2017 - United Kingdom - 7th March 2017 - The awards team at Corporate LiveWire are pleased to announce the globally awaited Innovation and Excellence awards winners of 2017

Mar 13, 2017, 15:18 by Michael Croft

STAT |  Tom Price suggested that there would be "significant concerns" with a House bill that would allow companies to require employees to undergo genetic testing.

Mar 13, 2017, 10:55 by Michael Croft

FORT MYERS, FL, UNITED STATES - Mar 13, 2017 - NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, and Definiens, the leader in Tissue Phenomics® solutions from biomarker discovery to meaningful diagnostics, today announced that they have expanded their alliance to develop and automate the analysis of new biomarker assays for clinical trials and routine clinical testing